Medical Design Technology -
14 Sep 2016 16:01
News The companies plan to jointly design and conduct single and multi-center clinical studies that employ advanced PET/MRI applications to interrogate the mechanistic effects of novel therapeutics for diabetes, obesity, and non-alcoholic fatty liver disease (NAFLD/NASH). Contributed Author: Profil Institute for Clinical Research, Inc. Topics: Medical Diagnostics
Share this Article